Bora Pharmaceuticals (HQ: Taipei, Taiwan), a premier international contract development and manufacturing organization (...
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...
Anbogen, a Taiwan-based clinical-stage biotech startup, has announced a drug supply collaboration to evaluate the combin...
Taiwan-headquartered Flat Medical, a leading innovator in medical technology, has announced its acquisition of key asset...
From left to right: Mr. John Cheng, Head of Primary Care at Healthway Medical Group; Mr. Wen-Chung Wu, Director of Econo...
Tanvex BioPharma, Inc., Taiwan-based biosimilar-focused biopharmaceutical company and a contract development and manufac...
Moderna, Inc. has announced that the Taiwan Food & Drug Administration (FDA) has approved an updated formulation of ...
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with R...
Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic investment into...
The BIO Asia–Taiwan 2024 Exhibition was held at the Taipei Nangang Exhibition Center Hall 1 (Tai...
Taiwan-based Formosa Pharmaceuticals has signed a non-binding terms agreement with US-based Eyenovia, Inc., whereby the ...
US-based Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, has ann...
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with Canadian firm Apotex Inc., f...
The BIO Asia–Taiwan 2024 Exhibition was held at the Taipei Nangang Exhibition Center Hall 1 (TaiNEX 1), from 26th ...
Taiwan-based startup JelloX Biotech Inc. has entered into a collaboration through a know-how agreement with Ma...
The opening day's sessions at BIO Asia-Taiwan 2024 on 26 July in Taipei, attracted a wide range of biotech professi...
BIO Asia–Taiwan 2024 commenced on 24 July at the Taipei Nangang Exhibition Center (TaiNEX 2), undeterred by the ap...
Taiwan-based startup Merdury Biopharmaceutical Corporation has signed a Memorandum of Understanding (MoU) with Health2Sy...
